Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Suzanne Ackloo, Peter J. Brown & Susanne Müller. (2017) Chemical probes targeting epigenetic proteins: Applications beyond oncology. Epigenetics 12:5, pages 378-400.
Read now
Read now
Articles from other publishers (21)
Yipeng Xu, Gabriela Pachnikova, Dorothea Przybilla, Reinhold Schäfer, Yingying Cui, Dan Zhou, Zihao Chen, An Zhao & Ulrich Keilholz. (2022) Evaluation of JQ1 Combined With Docetaxel for the Treatment of Prostate Cancer Cells in 2D- and 3D-Culture Systems. Frontiers in Pharmacology 13.
Crossref
Crossref
Tanggang Deng, Yugang Xiao, Yi Dai, Lin Xie & Xiong Li. (2021) Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Chao Wang, Yujing Zhang, Yudong Wu & Dongming Xing. (2021) Developments of CRBN-based PROTACs as potential therapeutic agents. European Journal of Medicinal Chemistry 225, pages 113749.
Crossref
Crossref
Zhonggui Gong, Gang Liu, Wenjing Liu, Hui Zou, Ruilong Song, Hongyan Zhao, Yan Yuan, Jianhong Gu, Jianchun Bian, Jiaqiao Zhu & Zongping Liu. (2021) The epigenetic regulator BRD4 is involved in cadmium-triggered inflammatory response in rat kidney. Ecotoxicology and Environmental Safety 224, pages 112620.
Crossref
Crossref
Samuel P. Boyson, Cong Gao, Kathleen Quinn, Joseph Boyd, Hana Paculova, Seth Frietze & Karen C. Glass. (2021) Functional Roles of Bromodomain Proteins in Cancer. Cancers 13:14, pages 3606.
Crossref
Crossref
Xuanrong Chen, Qianwang Ma, Zhiqun Shang & Yuanjie Niu. (2020) Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets. npj Precision Oncology 4:1.
Crossref
Crossref
Zhicheng Yao, Shida Yang, Hongyou Zhao, Huike Yang & Xin Jiang. (2019) RETRACTED ARTICLE: BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction. Cancer Gene Therapy 27:3-4, pages 226-234.
Crossref
Crossref
Madonna Peter, Shivani Kamdar & Bharati Bapat. 2019. Computational Epigenetics and Diseases. Computational Epigenetics and Diseases
247
263
.
Kazuki Mochizuki, Natsuyo Hariya, Kazue Honma & Toshinao Goda. 2019. Handbook of Nutrition, Diet, and Epigenetics. Handbook of Nutrition, Diet, and Epigenetics
745
759
.
Ai Liu, Dianxia Fan & Yanping Wang. (2018) The BET bromodomain inhibitor i-BET151 impairs ovarian cancer metastasis and improves antitumor immunity. Cell and Tissue Research 374:3, pages 577-585.
Crossref
Crossref
Young Hun Kim, Minsung Kim, Miyoun Yoo, Ji Eun Kim, Heung Kyoung Lee, Jung-Nyoung Heo, Chong Ock Lee, Minjin Yoo, Kwan-Young Jung, Chang-Soo Yun, Sung Woong Moon, Hye Kyung Chang, Chul-Woong Chung, Suhkneung Pyo, Sang Un Choi & Chi Hoon Park. (2018) A natural compound, aristoyagonine, is identified as a potent bromodomain inhibitor by mid-throughput screening. Biochemical and Biophysical Research Communications 503:2, pages 882-887.
Crossref
Crossref
Bin Chen, Jing Yu, Qianqian Wang, Yuanyuan Zhao, Li Sun, Changgen Xu, Xiangdong Zhao, Bo Shen, Mei Wang, Wenrong Xu & Wei Zhu. (2018)
Human Bone Marrow Mesenchymal Stem Cells Promote Gastric Cancer Growth via Regulating
c-Myc
. Stem Cells International 2018, pages 1-11.
Crossref
Crossref
Diego Martin-Sanchez, Miguel Fontecha-Barriuso, Maria Dolores Sanchez-Niño, Adrian M. Ramos, Ramiro Cabello, Carmen Gonzalez-Enguita, Andreas Linkermann, Ana Belén Sanz & Alberto Ortiz. (2018) Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields. Cell Death & Disease 9:2.
Crossref
Crossref
Simon Baumgart & Bernard Haendler. (2017) Exploiting Epigenetic Alterations in Prostate Cancer. International Journal of Molecular Sciences 18:5, pages 1017.
Crossref
Crossref
Kazuki Mochizuki, Natsuyo Hariya, Kazue Honma & Toshinao Goda. 2017. Handbook of Nutrition, Diet, and Epigenetics. Handbook of Nutrition, Diet, and Epigenetics
1
15
.
Jie Li, Peiqi Wang, Bihui Zhou, Jianyou Shi, Jie Liu, Xiangrong Li, Limei Fan, Yaxin Zheng & Liang Ouyang. (2016) Development of 4,5-dihydro-benzodiazepinone derivatives as a new chemical series of BRD4 inhibitors. European Journal of Medicinal Chemistry 121, pages 294-299.
Crossref
Crossref
Limei Wang, Xiuyin Wu, Ping Huang, Zhijun Lv, Yuping Qi, Xiujuan Wei, Pishan Yang & Fenghe Zhang. (2016) JQ1, a small molecule inhibitor of BRD4, suppresses cell growth and invasion in oral squamous cell carcinoma. Oncology Reports.
Crossref
Crossref
Mukesh Verma. (2016) Genome-wide association studies and epigenome-wide association studies go together in cancer control. Future Oncology 12:13, pages 1645-1664.
Crossref
Crossref
Aaron M. Udager, Angelo M. DeMarzo, Yang Shi, Jessica L. Hicks, Xuhong Cao, Javed Siddiqui, Hui Jiang, Arul M. Chinnaiyan & Rohit Mehra. (2016) Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics. The Prostate 76:9, pages 845-853.
Crossref
Crossref
Camille Jacques, François Lamoureux, Marc Baud’huin, Lidia Rodriguez Calleja, Thibaut Quillard, Jérôme Amiaud, Franck Tirode, Françoise Rédini, James E. Bradner, Dominique Heymann & Benjamin Ory. (2016) Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1. Oncotarget 7:17, pages 24125-24140.
Crossref
Crossref
Ester Fernandez-Salas, Shaomeng Wang & Arul M Chinnaiyan. (2016) Role of BET proteins in castration-resistant prostate cancer. Drug Discovery Today: Technologies 19, pages 29-38.
Crossref
Crossref